Register entry
CUBIST PHARMACEUTICALS LLC
- Registered sites
- 0
- Drug products
- 0
- Live patents
- 59
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
59Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| CUBICIN | DAPTOMYCIN | Sept 2028 |
| CUBICIN RF | DAPTOMYCIN | Nov 2030 |
| DIFICID | FIDAXOMICIN | Mar 2027 |
| DIFICID | FIDAXOMICIN | Jul 2027 |
| DIFICID | FIDAXOMICIN | Sept 2027 |
| DIFICID | FIDAXOMICIN | Jan 2028 |
| DIFICID | FIDAXOMICIN | May 2034 |
| DIFICID | FIDAXOMICIN | Nov 2034 |
| ENTEREG | ALVIMOPAN | Feb 2030 |
| SIVEXTRO | TEDIZOLID PHOSPHATE | Feb 2028 |
| SIVEXTRO | TEDIZOLID PHOSPHATE | Jun 2028 |
| SIVEXTRO | TEDIZOLID PHOSPHATE | Feb 2030 |
| SIVEXTRO | TEDIZOLID PHOSPHATE | Dec 2030 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | May 2028 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Nov 2028 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Sept 2032 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Mar 2033 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Mar 2034 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | May 2034 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Sept 2034 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Sept 2034 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Nov 2034 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Mar 2035 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Aug 2035 |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | Feb 2036 |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.